Connection
Christopher Hoyte to Infant
This is a "connection" page, showing publications Christopher Hoyte has written about Infant.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
0.333 |
|
|
|
-
Mehrpour O, Saeedi F, Hoyte C. Decision tree outcome prediction of acute acetaminophen exposure in the United States: A study of 30,000 cases from the National Poison Data System. Basic Clin Pharmacol Toxicol. 2022 Jan; 130(1):191-199.
Score: 0.079
-
Glatstein M, Bonifacio Rino P, de Pinho S, Scolnik D, Pivko-Levi D, Hoyte C. Levocarnitine for the Treatment of Valproic Acid-Induced Hyperammonemic Encephalopathy in Children: The Experience of a Large, Tertiary Care Pediatric Hospital and a Poison Center. Am J Ther. 2019 May/Jun; 26(3):e344-e349.
Score: 0.066
-
Glatstein M, Carbell G, Scolnik D, Rimon A, Hoyte C. Treatment of pediatric black widow spider envenomation: A national poison center's experience. Am J Emerg Med. 2018 06; 36(6):998-1002.
Score: 0.060
-
Heard K, Marlin MB, Nappe T, Hoyte CO. Common marijuana-related cases encountered in the emergency department. Am J Health Syst Pharm. 2017 Nov 15; 74(22):1904-1908.
Score: 0.059
-
Mehrpour O, Hoyte C, Delva-Clark H, Al Masud A, Biswas A, Schimmel J, Nakhaee S, Goss F. Classification of acute poisoning exposures with machine learning models derived from the National Poison Data System. Basic Clin Pharmacol Toxicol. 2022 Dec; 131(6):566-574.
Score: 0.021
-
Mehrpour O, Hoyte C, Amirabadizadeh A, Brent J. Clinical characteristics and time trends of hospitalized methadone exposures in the United States based on the Toxicology Investigators Consortium (ToxIC) case registry: 2010-2017. BMC Pharmacol Toxicol. 2020 07 22; 21(1):53.
Score: 0.018
-
Wang GS, Hoyte C, Roosevelt G, Heard K. The Continued Impact of Marijuana Legalization on Unintentional Pediatric Exposures in Colorado. Clin Pediatr (Phila). 2019 01; 58(1):114-116.
Score: 0.016
-
Pivko-Levy D, Munchnak I, Rimon A, Balla U, Scolnik D, Hoyte C, Voliovitch Y, Glatstein M. Evaluation of antivenom therapy for Vipera palaestinae bites in children: experience of two large, tertiary care pediatric hospitals. Clin Toxicol (Phila). 2017 Apr; 55(4):235-240.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|